$15.42
-1.71[-9.98%]
At close: May 9
$15.42
0[0.00%]
After Hours: 7:33PM EDT
ACADIA Pharmaceuticals
(NASDAQ:ACAD)ACADIA Pharmaceuticals Stock (NASDAQ:ACAD), Earnings Estimates, EPS, and Revenue
ACADIA Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS
$0.100
Quarterly Revenue
$205.8M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$726.4M
Analyze the earnings history of ACADIA Pharmaceuticals using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is ACADIA Pharmaceuticals (NASDAQ:ACAD) reporting earnings?
ACADIA Pharmaceuticals (ACAD) is scheduled to report earnings on July 31, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
What were the latest earnings per share (EPS) for ACADIA Pharmaceuticals (NASDAQ:ACAD)?
The Actual EPS was $0.10, which beat the estimate of $0.05.
What were ACADIA Pharmaceuticals’s (NASDAQ:ACAD) revenues?
The Actual Revenue was $205.8M, which missed the estimate of $208.4M.
Browse earnings estimates, EPS, and revenue on all stocks.